Australia markets open in 7 hours 5 minutes

TGT Dec 2025 150.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
17.150.00 (0.00%)
As of 02:39PM EDT. Market open.
Full screen
Loading interactive chart…
  • Yahoo Finance Video

    Crypto under pressure, Good Buy or Goodbye: Market Domination

    On today's episode of Market Domination, Hosts Julie Hyman and Josh Lipton discuss major market trends from Nvidia's (NVDA) slowdown to Novo Nordisk's (NVO) plans to expand manufacturing capabilities of its GLP-1 weight-loss drugs. As Nvidia continues on its downward trajectory after leading the S&P 500's (^GSPC) growth, B. Riley Wealth Chief Market Strategist Art Hogan believes the market can keep up its momentum without the chip giant: "I think it's a perfect example of a lot of folks being concerned that Nvidia and arguably Nvidia, Microsoft (MSFT), and Apple (AAPL) were such a big part of the 15% that the S&P 500 is higher this year on a year to date basis... But you're seeing basically three or four days where Nvidia has not been leading the charge, and the market's done very well. I think that continues throughout the second half of this year." The European Union has charged Apple under its Digital Markets Act, alleging that the tech giant's App Store practices prevent app developers from directing consumers to cheaper services. TECHnalysis Research President and Chief Analyst Bob O'Donnell believes the investigation is unlikely to conclude anytime soon, and that Apple will have to make some changes: "I do think Apple is going to have to make some tweaks, some things that they don't necessarily want to do, but at the end of the day, again, it's an important enough market that they're going to have to follow some of these requirements that the EU is putting into place. And therefore, long term, I don't think the impact is that big of a deal as far as the value of the company and the way people view the stock." Cryptocurrencies are also under pressure, with bitcoin (BTC-USD) having its worst trading day since March. Meanwhile, the health industry is making major moves, as Altimmune (ALT) reported positive results in Phase 2 trials for its weight-loss drug, a Teladoc Health (TDOC) study showed its AI models contributed to positive growth in diabetes management, and Novo Nordisk revealed plans to invest $4.1 billion in building out a manufacturing facility in Clayton, North Carolina for its GLP-1 weight-loss drugs. This post was written by Melanie Riehl

  • Barrons.com

    Target Stock Slips After Company Lowers More Prices

    Target stock is dropping after the company said it is cutting prices on another round of items, as retailers respond to consumers’ ongoing focus on value. On Tuesday, Target announced the return of its Target Circle Week in July, a sale that coincides with similar deal days from Amazon.com and Walmart Along with the sale, which will span items from toys to home goods, Target noted that it plans to reduce prices on some 3,500 products throughout the summer. Walmart noted as much when it reported results last month, and its results have been bolstered by Americans’ prioritizing essentials like groceries and low prices.

  • PR Newswire

    Target Announces Updates to Leadership Team

    Target Corporation (NYSE: TGT) today announced it has named Christina Hennington, currently chief growth officer, as chief strategy and growth officer, and Rick Gomez, currently chief food, essentials and beauty officer, as chief commercial officer, overseeing Target's merchandising business, both effective July 7. Lisa Roath, Target's chief marketing officer, will take on the role of chief merchandising officer of food, essentials and beauty in early 2025. The company is initiating an external